Key facts
- Springbok Analytics’s last known valuation is $25.0M (May 2025).
- It has raised $8.0M; the latest was Later Stage VC ($5.0M) in May 2025.
- Notable investors include Alumni Ventures, US National Science Foundation, National Institutes of Health, Virginia Innovation Partnership Corporation, TitletownTech — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Springbok Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for Springbok Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Springbok Analytics
Developer of a muscle analytics platform designed to transform magnetic resonance images into holistic, interactive three-dimensional twins of an athlete's exact musculature. The company's platform uses advanced imaging technology to identify and measure every individual muscle asymmetry and detect fat infiltration at the individual muscle level to transform MRI data into detailed, 3D representations, enabling coaches to track the progress and efficacy of programs that are created for performance and injury recovery.
- Sector
- Healthcare
- HQ
- Charlottesville, VA, United States
- Founded
- 2013
- Employees
- 44
- Website
- springbokanalytics.com/
- Ownership
- Privately Held (backing)
Springbok Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Springbok Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Springbok Analytics in its N-PORT filings yet. We sweep new filings monthly.